[The role of clinico-pharmacogenetic associations in the prognosis of the outcomes in pneumonias].
In search of reliable genetic markers of protracted and complicated pneumonia, the authors studied blood groups, haptoglobin phenotype, sulfadimisine acetylation. These markers proved essential for predicting pneumonia course and prognosis.
Nikitin
A V
AV
Roldugin
S V
SV
Sil'vestrov
V P
VP
D000017:ABO Blood-Group System / Q000097:blood; D000107:Acetylation; D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D005819:Genetic Markers; D006242:Haptoglobins / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D010597:Pharmacogenetics; D010641:Phenotype; D011014:Pneumonia / Q000097:blood / Q000188:drug therapy* / Q000235:genetics; D011379:Prognosis; D013424:Sulfanilamides / Q000097:blood; D016896:Treatment Outcome
D000017:ABO Blood-Group System; D005819:Genetic Markers; D006242:Haptoglobins; D013424:Sulfanilamides
Rol' kliniko-farmakogeneticheskikh assotsiatsiĭ v prognoze iskhodov pnevmoniĭ.